Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Actifed C

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 18 USDMF, 10 CEP/COS, 3 JDMF, 4 EU WC, 4 KDMF, 18 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

197 FDF Dossiers, 51 FDA Orange Book, 5 Europe, 68 Canada, 23 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1.2GM, TABLET, EXTENDED RELEASE;ORAL - 600MG, TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG, TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 30MG;600MG, TABLET, EXTENDED RELEASE;ORAL - 60MG;1.2GM, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 12 Rochem International Inc, 24 SPI Pharma, 24 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 13 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 17 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 19 Actylis, 4 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 1 Avesta Pharma, 40 BASF, 2 Bioplus Life Sciences, 4 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 4 Finar, 16 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 23 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 19 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

124 Fillers, Diluents & Binders, 80 Thickeners and Stabilizers, 66 Solubilizers, 65 Coating Systems & Additives, 50 Taste Masking, 49 Direct Compression, 49 Topical, 47 Disintegrants & Superdisintegrants, 44 Controlled & Modified Release, 40 Parenteral, 37 Granulation, 36 Film Formers & Plasticizers, 28 Lubricants & Glidants, 25 Chewable & Orodispersible Aids, 20 Rheology Modifiers, 19 Emulsifying Agents, 18 Co-Processed Excipients, 13 Surfactant & Foaming Agents, 13 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

49 News #PharmaBuzz

49 News #PharmaBuzz

MARKET PLACE

27 APIs

27 APIs

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 JP, 5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
04/06/2025	Granules India Limited	India	GRANULES INDIA LIMITED Hyderabad IN	R1-CEP 2009-201 - Rev 03	Guaifenesin	2018-11-27	Valid	Chemical		615
04/06/2025	Synthokem Labs	India	SYNTHOKEM LABS PRIVATE LIMITED Hyderabad IN	CEP 2019-065 - Rev 01	Guaifenesin, Unit-II	2025-01-15	Valid	Chemical		615

Actifed C

Actifed C

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

63 API Suppliers

18 USDMF

10 CEP/COS

3 JDMF

4 EU WC

4 KDMF

18 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

197 FDF Dossiers

51 FDA Orange Book

5 Europe

68 Canada

23 South Africa

50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1.2GM

TABLET, EXTENDED RELEASE;ORAL - 600MG

TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG

TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG

TABLET, EXTENDED RELEASE;ORAL - 30MG;600MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;1.2GM

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

12 Rochem International Inc

24 SPI Pharma

24 DKSH

2 Pharm-RX Chemical

9 Faran Shimi Pharmaceutical

13 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

17 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

19 Actylis

4 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

1 Avesta Pharma

40 BASF

2 Bioplus Life Sciences

4 Clariant

16 Corel Pharma Chem

6 DFE Pharma

4 Finar

16 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

33 Kerry

4 Kima Chemical

6 Lonza Capsugel

5 Lubrizol Life Science Health

23 Microlex e.U

3 Nanjing Bold Chemical

2 Nomisma Healthcare

5 Novo Excipients

4 Pharmatrans-Sanaq

11 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

56 Roquette

19 Seppic